Intellia Therapeutics (NTLA) Gains (Losses) on Sale of Assets & Investments (2019 - 2026)
Intellia Therapeutics (NTLA) reported Non Operating Investment Income of -$790,000 for Q2 2026, compared with $1.34 million a year earlier.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Gains (Losses) on Sale of Assets & Investments (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Intellia Therapeutics' Non Operating Investment Income came in at -$1.28 million; for FY2024, it was -$32.57 million.
- By year, Non Operating Investment Income came in at $3.64 million in FY2023, -$1.64 million in FY2022, -$2.13 million in FY2021 and -$260,000 in FY2020.
- Five-year quarterly Non Operating Investment Income spans a low of -$20.35 million in Q2 2024 and a high of $4.45 million in Q3 2024.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$1.27 million (Q1 2026), -$2.65 million (Q4 2025) and $3.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Intellia Therapeutics | 1.57 Bn | -171.10 Mn | - | -10.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -10.39 Mn |
| Jun 30, 2026 | -790,000.00 |
| Mar 31, 2026 | -1.27 Mn |
| Dec 31, 2025 | -2.65 Mn |
| Sep 30, 2025 | 3.44 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | -2.13 Mn |
| Dec 31, 2024 | -3.08 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | -20.35 Mn |
| Mar 31, 2024 | -6.07 Mn |
| Dec 31, 2023 | 1.99 Mn |
| Sep 30, 2023 | 142,000.00 |
| Jun 30, 2023 | -1.48 Mn |
| Mar 31, 2023 | 2.99 Mn |
| Dec 31, 2022 | 3.43 Mn |
| Sep 30, 2022 | 991,000.00 |
| Jun 30, 2022 | -932,000.00 |
| Mar 31, 2022 | -5.13 Mn |
| Dec 31, 2021 | -1.95 Mn |
API Access
Intellia Therapeutics Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();